European Journal of Clinical Pharmacology

, Volume 34, Issue 2, pp 145–150

Effect of prednisolone and ketotifen onβ2-adrenoceptors in asthmatic patients receivingβ2-bronchodilators

  • O. E. Brodde
  • U. Howe
  • S. Egerszegi
  • N. Konietzko
  • M. C. Michel
Originals

Summary

In 13 patients with bronchial asthma, who were onβ2-adrenergic bronchodilator therapy, the effects of prednisolone and ketotifen on lymphocyteβ2-adrenoceptor density and -responsiveness were investigated. The mean lymphocyteβ2-adrenoceptor density and -responsiveness was significantly lower than in healthy controls, presumably due to the long-termβ2-adrenergic bronchodilator treatment. Both prednisolone 100 mg i.v. and ketotifen 1 mg b.d.p.o. for 6 days rapidly improved lymphocyteβ2-adrenoceptor function. 16 h after prednisolone and about 6 days after the first dose of ketotifen lymphocyteβ2-adrenoceptor density and-responsiveness had risen to values within the range in normal volunteers.

The improvement of lymphocyteβ2-adrenoceptor function was accompanied by a significant increase in peak expiratory flow rate before and after inhalation of salbutamol.

It is concluded that prednisolone and ketotifen may act beneficially on the recovery ofβ2-adrenoceptor responsiveness toβ2-adrenergic bronchodilators in tolerant asthmatic patients.

Key words

asthma ketotifen prednisolone lymphocyte beta2-adrenoceptors beta-adrenoceptor desensitization tachyphylaxis salbutamol terbutaline theophylline 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Paterson JW, Woolcock AJ, Shenfield GM (1979) Bronchodilator drugs. Am Rev Respir Dis 120: 1149–1188Google Scholar
  2. 2.
    Nelson HS (1986) Adrenergic therapy of bronchial asthma. J Allergy Clin Immunol 77: 771–785Google Scholar
  3. 3.
    Harden TK (1983) Agonist-induced desensitization of theβ-adrenergic receptor-linked adenylate cyclase. Pharmacol Rev 35: 5–32Google Scholar
  4. 4.
    Stiles GL, Caron MG, Lefkowitz RJ (1984)β-Adrenergic receptors: Biochemical mechanisms of physiological regulation. Physiol Rev 64: 661–743Google Scholar
  5. 5.
    Jenne JW (1982) Whither beta-adrenergic tachyphylaxis? J Allergy Clin Immunol 70: 413–416Google Scholar
  6. 6.
    Davis C, Conolly ME (1980) Tachyphylaxis toβ-adrenoceptor agonists in human bronchial smooth muscle: studies in vitro. Br J Clin Pharmacol 10: 417–423Google Scholar
  7. 7.
    Avner BP, Jenne JW (1981) Desensitization of isolated human bronchial smooth muscle toβ-receptor agonists. J Allergy Clin Immunol 48: 51–57Google Scholar
  8. 8.
    Guillot C, Fornaris M, Badier M, Orehek J (1984) Spontaneous and provoked resistance to isoproterenol in isolated human bronchi. J Allergy Clin Immunol 74: 713–718Google Scholar
  9. 9.
    Motulsky HJ, Insel PA (1982) Adrenergic receptors in man. Direct identification, physiologic regulation and clinical alterations. N Engl J Med 307: 18–29Google Scholar
  10. 10.
    Tashkin DP, Conolly ME, Deutsch RI, Hui KKP, Littner M, Scarpace P, Abrass I (1982) Sbusensitization of beta-adrenoceptors in airways and lymphocytes of healthy and asthmatic subjects. Am Rev Respir Dis 125: 185–193Google Scholar
  11. 11.
    Hui KKP, Conolly ME, Tashkin DP (1982) Reversal of human lymphocyteβ-adrenoceptor desensitization by glucocorticoids. Clin Pharmacol Ther 32: 566–571Google Scholar
  12. 12.
    Samuelson WM, Davies AO (1984) Hydrocortisone-induced reversal of beta-adrenergic receptor uncoupling. Am Rev Respir Dis 130: 1023–1026Google Scholar
  13. 13.
    Brodde O-E, Brinkmann M, Schemuth R, O'Hara N, Daul A (1985) Terbutaline-induced desensitization of human lymphocyteβ 2-adrenoceptors. Accelerated restoration ofβ-adrenoceptor responsiveness by prednisone and ketotifen. J Clin Invest 76: 1096–1101Google Scholar
  14. 14.
    Böyum A (1968) Isolation of mononuclear cells and granulocytes from human blood. Scand J Clin Lab Invest 21 [Suppl 97]: 77–89Google Scholar
  15. 15.
    Gilman AG (1970) A protein binding assay for adenosine 3′, 5′-cyclic monophosphate. Proc Natl Acad Sci 67: 305–312Google Scholar
  16. 16.
    Scatchard G (1949) The attraction of proteins for small molecules and ions. Ann N Y Acad Sci 51: 660–672Google Scholar
  17. 17.
    O'Hara N, Daul AE, Fesel R, Siekmann U, Brodde O-E (1985) Different mechanisms underlying reducedβ 2-adrenoceptor responsiveness in lymphocytes from neonates and old subjects. Mech Ageing Dev 31: 115–122Google Scholar
  18. 18.
    Szentivanyi A (1968) The beta-adrenergic theory of the atopic abnormality in bronchial asthma. J Allergy 42: 203–232Google Scholar
  19. 19.
    Abrass IB, Scarpace PJ (1981) Human lymphocyte beta-adrenergic receptors are unaltered with age. J Gerontol 36: 298–301Google Scholar
  20. 20.
    Landmann R, Bittiger H, Bühler FR (1981) High affinity beta2-adrenergic receptors in mononuclear leukocytes: Similar density in young and old normal subjects. Life Sci 29: 1761–1771Google Scholar
  21. 21.
    Middeke M, Remien J, Holzgreve H (1984) The influence of sex, age, blood pressure and physical stress onβ 2-adrenoceptor density in mononuclear cells. J Hypertens 2: 261–264Google Scholar
  22. 22.
    Brodde O-E, Kretsch R, Ikezono K, Zerkowski H-R, Reidemeister J Chr (1986) Humanβ-adrenoceptors: Relation of myocardial and lymphocyteβ-adrenoceptor density. Science 231: 1584–1585Google Scholar
  23. 23.
    Brodde O-E (1987) Cardiac beta-adrenergic receptors. ISI Atlas Sci: Pharmacology 1: 107–112Google Scholar
  24. 24.
    Michel MC, Beckeringh JJ, Ikezono K, Kretsch R, Brodde O-E (1986) Lymphocyte beta2-adrenoceptors mirror precisely beta2-adrenoceptor, but poorly beta1-adrenoceptor changes in the human heart. J Hypertens 4 [Suppl 6]: S215-S218Google Scholar
  25. 25.
    Committee on drugs. The American Academy of Allergy and Immunology (Chairman: Sly RM) (1985) Adverse effects and complications of treatment with beta-adrenergic agonist drugs. J Allergy Clin Immunol 75: 443–449Google Scholar
  26. 26.
    Martinsson A, Larsson K, Hjemdahl P (1987) Studies in vivo and in vitro of terbutaline-inducedβ-adrenoceptor desensitization in healthy subjects. Clin Sci 72: 47–54Google Scholar
  27. 27.
    Beckeringh JJ, Brodde O-E, Daul A, Michel MC, Wang XL (1987) Haemodynamic and lymphocyteβ 2-adrenoceptor changes during procaterol treatment in man. Br J Pharmacol 90 [Suppl]: 43 P (abstract)Google Scholar
  28. 28.
    Goldie RG, Spina D, Henry PJ, Lulich KM, Paterson JW (1986) In vitro responsiveness of human asthmatic bronchus to carbachol, histamine,β-adrenoceptor agonists and theophylline. Br J Clin Pharmacol 22: 669–676Google Scholar
  29. 29.
    Bretz U, Martin U, Mazzoni L, Ney UM (1983)β-Adrenergic tachyphylaxis in the rat and its reversal and prevention by ketotifen. Eur J Pharmacol 86: 321–328Google Scholar
  30. 30.
    Tinkelman DG, Moss BA, Bukantz SC, Sheffer AL, Dobken JH, Chodosh S, Cohen BM, Rosenthal RR, Rappaport I, Buckley CE, Chusid EL, Deutsch AJ, Settipane GA, Burns RBP (1985) A multicenter trial of the prophylactic effect of ketotifen, theophylline, and placebo in atopic asthma. J Allergy Clin Immunol 76: 487–497Google Scholar
  31. 31.
    Dyson AJ, Mackay AD (1980) Ketotifen in adult asthma. Br Med J 280: 360–361Google Scholar
  32. 32.
    Kumagai A, Tomioka H, Shida T, Takahashi T, Muranaka M (1980) Clinical evaluation of a new orally active anti-anaphylactic compound: Ketotifen (HC 20–511) in Japanese adult asthmatics. Schweiz Med Wochenschr 110: 197–203Google Scholar
  33. 33.
    Lane DJ (1980) A steroid sparing effect of ketotifen in steroid-dependent asthmatics. Clin Allergy 10: 519–525Google Scholar
  34. 34.
    Lebeau B, Gence B, Bourdain M, Loria Y (1982) Le ketotifen dans le traitement preventif de l'asthme. Poumon-Coeur 38: 125–129Google Scholar
  35. 35.
    Lichtenstein LM, Margolis S (1968) Histamine release in vitro: Inhibition by catecholamines and methylxanthines. Science 161: 902–903Google Scholar
  36. 36.
    Kaliner M, Austen KF (1973) A sequence of biochemical events in the antigen-induced release of chemical mediators from sensitized human lung tissue. J Exp Med 138: 1077–1094Google Scholar
  37. 37.
    Butchers PR, Skidmore IF, Vardey CJ, Wheeldon A (1980) Characterization of the receptor mediating the anti-anaphylactic effects ofβ-adrenoceptor agonists in human lung tissue in vitro. Br J Pharmacol 71: 663–667Google Scholar
  38. 38.
    Petersson BA (1984) Sustained inhibition of antigen-induced histamine release from human lung by theβ 2-adrenoceptor agonist terbutaline. Allergy 39: 351–357Google Scholar

Copyright information

© Springer-Verlag 1988

Authors and Affiliations

  • O. E. Brodde
    • 1
  • U. Howe
    • 1
  • S. Egerszegi
    • 2
  • N. Konietzko
    • 2
  • M. C. Michel
    • 1
  1. 1.Biochemical Research Laboratory, Medizinische Klinik und Poliklinik, Division of Renal and Hypertensive DiseasesUniversity of EssenEssenGermany
  2. 2.Ruhrlandklinik EssenEssenGermany

Personalised recommendations